• SENSEX 74,534.42
    383.38 (+0.52%)
  • BANKNIFTY 54,909.65
    642.25 (+1.18%)
  • Jio Platforms
    1,435.55 1,490.00(%)
  • NSE
    1,778.10 1,640.25(%)
  • Dalmia BharatLtd
    1,320.00 1,403.50(%)
  • Anand Rathi Wea.
    2,257.60 1,354.00(%)
  • Sagility
    41.79 35.82(%)
  • Ather Energy
    1,778.00 1,741.90(%)
  • Laurus Labs
    2,388.00 2,245.00(%)
  • UltraTech Cem.
    11,005.00 10,329.00(%)
  • Reliance Industries
    1,152.50 1,152.30(%)
  • Indian Hotels Co
    824.00 816.00(%)
  • Tonbo Imaging
    1,330.00 1,343.80(%)
  • Trent
    3,059.00 3,399.75(%)
  • HDFC Bank
    695.50 1,017.90(%)
  • Hexaware Tech.
    499.25 400.35(%)
  • Godrej Consumer
    777.65 810.35(%)
  • Suzlon Energy
    33.21 36.30(%)
  • Diamond Power
    345.90 406.80(%)
  • Equitas Sma. Fin
    47.26 51.30(%)
  • APL Apollo Tubes
    2,166.05 1,691.05(%)
  • Global Health
    1,266.90 955.20(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Brawn Biotech Ltd Trading

  • Indian Private
  • BSE Code : 4887.0
  • ISIN : INE899B01015
25.87 0 (1.85%)
  • As on 30 Oct 2026 (EOD)

  • Today’s Low

    25.87

  • Today’s High

    26.64

  • Open

    26.64

  • Perv Close

    25.40

  • 52W Low

    17.71

  • 52W High

    26.64

Key Indicators

  • P/E(TTM)

    9.05

  • Mar.Cap (₹Cr.)

    7.76

  • Div & Yield %

    0.00

  • Book Value(₹)

    14.46

  • Debt-Equity Ratio

    1.85

  • AGM Date

    28-Oct-2026

  • EPS

    2.86

  • P/E Ratio

    9.05

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    7.76

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    3.00

  • BV (₹)

    14.50

  • Sales( ₹ in Cr.)

    16.98

  • NP (in Cr.)

    0.94

  • NP Var(%)

    154.0

  • Div%

    0.0

  • CPS (₹)

    3.50

  • EPS (₹)

    3.10

  • Traded Value (₹ in Lakhs)

    7.76

  • 52 Week High

    26.64

  • 52 Week Low

    17.71

  • Price BSE

    26.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    7.76

  • P/C Ratio

    7.30

  • P/E Ratio

    8.30

  • Price Vs.BV

    3.10

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 16.98 13.46 16.49 22.23 8.62 34.98
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 16.98 13.46 16.49 22.23 8.62 34.98
Other Income 0.45 0.09 0.09 0.01 0.00 0.31
Stock Adjustments -0.40 4.45 1.23 0.07 4.47 -0.13
Total Income 17.03 18.00 17.81 22.31 13.09 35.16
EXPENDITURE :            
Raw Materials 14.11 16.38 15.59 19.24 11.05 29.89
Power and Fuel Cost 0.06 0.10 0.08 0.06 0.02 0.04
Employee Cost 0.68 1.13 1.40 1.40 1.80 2.36
Other Manufacturing Expenses 0.12 0.29 0.35 0.34 0.40 1.64
Selling and Administration Expenses 1.91 1.79 1.76 1.55 1.81 1.50
Miscellaneous Expenses 0.01 0.00 0.01 0.00 0.01 0.01
Employee Benefit Expenses 0.68 1.13 1.40 1.40 1.80 2.36
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 16.89 19.69 19.20 22.60 15.09 35.44
Operating Profit 0.12 -1.68 -1.38 -0.29 -2.00 -0.29
Interest 0.00 0.00 0.06 0.01 0.06 0.04
Gross Profit 0.12 -1.68 -1.44 -0.30 -2.06 -0.33
Depreciation 0.12 0.11 0.10 0.11 0.05 0.03
Profit Before Tax 0.00 -1.79 -1.54 -0.41 -2.11 -0.36
Current Tax 0.00 0.00 0.00 -0.01 0.00 0.28
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax -0.94 -0.06 -0.30 0.46 -0.47 -0.08
Reported Net Profit 0.94 -1.74 -1.25 -0.87 -1.64 -0.55
Extraordinary Items 0.00 0.00 -0.01 0.00 0.00 0.00
Adjusted Net Profit 0.94 -1.74 -1.24 -0.87 -1.64 -0.55
Adjustment below Net Profit 0.04 0.04 3.31 -0.04 0.07 0.08
P & L Balance brought forward -1.76 -0.05 0.00 2.10 3.68 4.14
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -0.78 -1.76 2.06 1.19 2.10 3.68
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 3.14 -5.80 -4.16 -2.89 -5.48 -1.84
Earnings Per Share(Adj)-Unit Curr 3.14 -5.80 -4.16 -2.89 -5.48 -1.84
Book Value 14.46 11.21 16.88 21.03 24.07 29.31
Book Value(Adj)-Unit Curr 14.46 11.21 16.88 21.03 24.07 29.31

Shareholding Pattern

  • Promoter Group

    52.94%

  • Public Share Holding

    47.06%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 68,100 2.27 0 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,520,294 50.67 1,417,894 20
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,588,394 52.94 1,417,894 21
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 10,400 0.35 0 1
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 10,400 0.35 0 1
2] Non Institution
Bodies Corporate 8,345 0.28 8,245 16
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 36,824 1.23 16,824 32
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 8,371 0.28 8,371 20
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 92,732 3.09 92,732 3
Individuals holding nominal share capital up to Rs. 1 lakh 823,112 27.43 758,105 3,169
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 432,122 14.40 432,122 1
Sub Total 1,401,506 46.71 1,316,399 3,241
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 3,000,300 100.00 2,734,293 3,263

Company Background

Brawn Biotech LtdTrading

  • Brawn Biotech Ltd
  • BSE Code : 4887.0
  • ISIN : INE899B01015

  • Incorporation Year

    1985

  • Registered Office

    C-64 Lajpat Nagar-1 1st Floor
    , New Delhi,
    New Delhi-110024

  • Telephone

  • FAX

  • Chairman

    B R Gupta

  • Managing Director

  • Company Secretary

    Priyanka Sharma

  • Auditor

    Rajiv Udai & Associates/GDSM and Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    RCMC Share Registry P Ltd
    B-106 Sector-2 ,
    ,
    Mumbai - Noida-201301

Brawn Biotech Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Brawn Biotech 25.87 17.43 16.98 9.05 0.00
Abbott India 26,107.90 7,217.19 6,929.05 34.36 43.78
Astrazeneca Phar 6,298.05 2,304.07 2,275.58 92.82 27.86
Glaxosmi. Pharma 2,515.65 3,932.76 3,790.20 40.19 58.17
Novartis India 1,813.30 393.10 354.33 45.79 15.94
Cipla 1,357.00 20,102.60 18,979.95 41.36 13.88
Bliss GVS Pharma 682.50 773.53 729.81 63.43 12.51
Amrutanjan Healt 493.40 520.13 502.55 26.43 24.16
Fermenta Biotec. 439.75 474.15 450.25 20.53 18.77
Guj. Themis Bio. 374.85 168.25 165.82 100.23 18.05
Ambalal Sarabhai 35.00 19.52 3.94 64.81 6.77